Inactive Instrument

Highlights Novoheart Holdings Inc.

Equities

NVH

CA67011V1076

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Novomed Limited completed the acquisition of 12.6% stake in Novoheart Holdings Inc..	20-11-17	CI
Novomed Limited entered into a definitive arrangement agreement to acquire 12.6% stake in Novoheart Holdings Inc. for CAD 12.6 million.	20-09-14	CI
Novoheart Holdings Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-31	CI
Novoheart Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-19	CI
Novoheart Announces the Completion of a Research and Development Contract Sponsored by a Top 10 Global Pharma	20-01-21	CI
Novoheart Announces an Exclusive Licensing Agreement with Harvard University's Office of Technology Development	19-12-16	CI
Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca	19-11-26	CI
Novoheart Holdings Inc. Reports Earnings Results for the First Quarter Ended September 30, 2019	19-11-18	CI
Novoheart Holdings Inc. Demonstrates Advanced Capabilities for Drug Screening as Well as Disease Modeling Which Can Lead to Safer Drugs with Better Efficacy, According to New Research	19-09-09	CI
Novoheart Holdings Inc. Reports Earnings Results for the Full Year Ended June 30, 2019	19-09-05	CI
Novoheart Holdings Inc. completed the acquisition of Xellera Therapeutics Limited from Ruby Fame Limited, Marine Bridge International Limited and Ronald Li.	19-06-27	CI
Novoheart Holdings Inc. entered into a definitive agreement to acquire Xellera Therapeutics Limited from Ruby Fame Limited, Marine Bridge International Limited and Ronald Li for CAD 32.6 million.	19-05-27	CI
Novoheart Holdings Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2019	19-05-17	CI
Novoheart Holdings Inc. Reports Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2018	19-03-01	CI
Novoheart Holdings Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2018	18-11-22	CI
Novoheart Enters into A Service Agreement with Xellera Therapeutics Limited	18-10-31	CI
Novoheart Holdings Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2018	18-08-22	CI
Novoheart Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	18-05-11	CI
Novoheart to Debut New Human Heart-in-a-Jar 2.0 Technology At the 2018 International Society for Stem Cell Research Annual Meeting	18-05-02	CI
Novoheart Files Patent Application on Disease Modeling Based on Landmark Research	18-03-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Novoheart Holdings Inc.

Equities

NVH

CA67011V1076

Highlights

Filters